Neutrophil mediated immunity |
3.03E−12 |
MHC Class II receptor activity |
7.67E−03 |
Neutrophil activation involved in immune response |
3.03E−12 |
Activin binding |
7.67E−03 |
Neutrophil degranulation |
4.62E−12 |
MHC Class II protein complex binding |
7.67E−03 |
Interferon-gamma-mediated signaling pathway |
4.62E−12 |
MHC protein complex binding |
7.67E−03 |
Cytokine-mediated signaling pathway |
9.91E−11 |
Transforming growth factor beta binding |
7.67E−03 |
Cellular response to interferon-gamma |
5.79E−10 |
Phosphotyrosine residue binding |
7.67E−03 |
Negative regulation of amyloid precursor protein catabolic process |
7.71E−05 |
Transforming growth factor beta receptor binding |
7.67E−03 |
Regulation of amyloid-beta formation |
7.94E−05 |
Amyloid-beta binding |
7.67E−03 |
Positive regulation of intracellular signal transduction |
1.62E−04 |
Scavenger receptor activity |
1.04E−02 |
Positive regulation of actin nucleation |
1.68E−04 |
Protein phosphorylated amino acid binding |
1.09E−02 |
Endocytosis |
2.26E−04 |
Low-density lipoprotein receptor activity |
1.42E−02 |
Regulation of mast cell degranulation |
3.07E−04 |
Phosphatidylinositol bisphosphate binding |
1.42E−02 |
Regulation of apoptotic process |
3.07E−04 |
Protein kinase binding |
1.42E−02 |
Extracellular matrix organization |
3.07E−04 |
Clathrin heavy chain binding |
1.91E−02 |
Negative regulation of amyloid-beta formation |
4.01E−04 |
Lipoprotein particle receptor activity |
1.95E−02 |
Antigen receptor-mediated signaling pathway |
4.01E−04 |
GTPase regulator activity |
2.02E−02 |
Negative regulation of extrinsic apoptotic signaling pathway |
5.26E−04 |
Actin binding |
2.23E−02 |
Regulation of amyloid-beta clearance |
5.77E−04 |
Type II transforming growth factor beta receptor binding |
2.30E−02 |
T cell receptor signaling pathway |
5.77E−04 |
Low-density lipoprotein particle binding |
2.30E−02 |
Cellular response to transforming growth factor beta stimulus |
1.09E−03 |
Peptidase activity, acting on L-amino acid peptides |
2.30E−02 |